These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35621238)

  • 1. Comment on "intralesional injection of MMR, BCG, and candida albicans antigen in treatment of multiple recalcitrant warts".
    Mungmunpuntipantip R; Wiwanitkit V
    J Cosmet Dermatol; 2022 Dec; 21(12):7211. PubMed ID: 35621238
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study between intralesional injection of MMR, BCG, and candida albicans antigen in treatment of multiple recalcitrant warts.
    Eldahshan RM; Ashry WMO; Elsaie ML
    J Cosmet Dermatol; 2022 Mar; 21(3):1120-1126. PubMed ID: 34998000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional injection of Candida albicans antigen versus measles, mumps, and rubella vaccine for treatment of plantar warts.
    Rageh RM; Hewedy ES; Hegab DS
    Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):1-5. PubMed ID: 33765749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of intralesional wart therapy.
    Muse ME; Stiff KM; Glines KR; Cline A; Feldman SR
    Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
    Nofal A; El-Arab RE; Nasr M; Alakad R
    J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional Candida antigen versus intralesional vitamin D3 in the treatment of recalcitrant multiple common warts.
    Abdel Razik LH; Obaid ZM; Fouda I
    J Cosmet Dermatol; 2021 Oct; 20(10):3341-3346. PubMed ID: 34228877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Study of Intralesional Vitamin D3 Injection and Candida Albicans Antigen in Treating Plantar Warts.
    Abdelaal MA; Abdelaziz HM; Ahmed KA; Elsaie ML
    J Drugs Dermatol; 2021 May; 20(5):546-549. PubMed ID: 33938709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional vitamin D3 versus Candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts: A comparative case-control study.
    Fathy G; Sharara MA; Khafagy AH
    Dermatol Ther; 2019 Sep; 32(5):e12997. PubMed ID: 31225688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative.
    Nofal A; Adel L; Fawzy M; Elkholy BM
    Dermatol Ther; 2022 Jun; 35(6):e15440. PubMed ID: 35285995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of intralesional injection of
    Hodeib AAE; Al-Sharkawy BG; Hegab DS; Talaat RAZ
    J Dermatolog Treat; 2021 Sep; 32(6):663-668. PubMed ID: 31682472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in cutaneous warts: comparative clinical Study between MMR vaccine, tuberculin, and BCG Vaccine.
    Shaker ESE; Doghim NN; Hassan AM; Musafa SS; Fawzy MM
    J Cosmet Dermatol; 2021 Aug; 20(8):2657-2666. PubMed ID: 33410249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional Candida albicans antigen versus intralesional zinc sulfate in treatment of cutaneous warts.
    Youssef EMK; Eissa MAA; Bakr RM
    Arch Dermatol Res; 2023 Jul; 315(5):1305-1314. PubMed ID: 36567351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida albicans Immunotherapy for Verrucae Plantaris.
    Vlahovic TC; Spadone S; Dunn SP; Fussell T; Hersh I; Green T; Merrill J; Ghosh P; Tran T
    J Am Podiatr Med Assoc; 2015 Sep; 105(5):395-400. PubMed ID: 26429607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finger Necrosis After Cutaneous Wart Intralesional Injection with Candida albicans Antigen: A Case Report.
    Graham JG; Tosti R
    JBJS Case Connect; 2023 Jan; 13(1):. PubMed ID: 36947640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional immunotherapy for pediatric warts: A review.
    Fields JR; Saikaly SK; Schoch JJ
    Pediatr Dermatol; 2020 Mar; 37(2):265-271. PubMed ID: 31930595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts.
    Marei A; Nofal A; Alakad R; Abdel-Hady A
    J Cosmet Dermatol; 2020 Mar; 19(3):758-762. PubMed ID: 31328869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
    Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
    J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
    Nofal A; Alakad R
    J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recalcitrant warts with Bacillus Calmette-Guérin: a promising new approach.
    Nofal A; Yosef A; Salah E
    Dermatol Ther; 2013; 26(6):481-5. PubMed ID: 24552412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida albicans intralesional injection immunotherapy of warts.
    Signore RJ
    Cutis; 2002 Sep; 70(3):185-92. PubMed ID: 12353895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.